ストックスクリーナーアプリを入手
15.14
1.37%
-0.21
アフターアワーズ：
15.06
-0.08
-0.53%
前日終値:
$15.35
開ける：
$15.34
24時間の取引高:
1.22M
Relative Volume:
0.92
時価総額：
$1.13B
収益：
$254.91M
当期純損益:
$-103.48M
株価収益率:
-10.79
EPS:
-1.4036
ネットキャッシュフロー:
$-148.35M
1週間 パフォーマンス:
+1.14%
1か月 パフォーマンス:
-6.83%
6か月 パフォーマンス:
+8.38%
1年 パフォーマンス:
-25.53%
1日の値動き範囲:
$14.80
$15.52
1週間の範囲:
$14.71
$15.57
52週間の値動き範囲:
$10.95
$23.02
Schrodinger Inc Stock (SDGR) Company Profile
Compare SDGR vs VEEV, BTSG, HQY, TEM, TXG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
15.14 | 1.14B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
203.77 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
59.74 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
100.61 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
43.87 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
47.27 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-09-30 | 開始されました | Goldman | Neutral |
| 2025-08-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-08-14 | 開始されました | Barclays | Overweight |
| 2025-07-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-07-02 | 開始されました | Leerink Partners | Outperform |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 再開されました | Piper Sandler | Overweight |
| 2022-12-19 | 開始されました | Goldman | Neutral |
| 2022-03-01 | 開始されました | Citigroup | Buy |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-11-11 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-10-13 | 開始されました | Berenberg | Buy |
| 2021-09-01 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 開始されました | Craig Hallum | Buy |
| 2020-11-23 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-10-12 | アップグレード | Jefferies | Hold → Buy |
| 2020-03-02 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-02 | 開始されました | Jefferies | Hold |
| 2020-03-02 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Schrodinger Inc (SDGR) 最新ニュース
Rubric Capital Management LP Purchases 1,828,502 Shares of Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger Inc (SDGR) Cash Flow - TradingKey
Schrödinger launches AI co-scientist for drug discovery - Investing.com
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery - Yahoo Finance
Exclusive: Schrödinger CEO 'couldn't be more pleased to be wrong' in launch of AI agent Bunsen - Endpoints News
Schrodinger Inc (SDGR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Schrodinger Inc (SDGR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AI Stocks: Why Tempus AI (NASDAQ:TEM), Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrodinger (NASDAQ:SDGR) Are in Focus - Kalkine Media
TradingKey - TradingKey
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrodinger Inc (SDGR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SDGR|Schrodinger Inc|Price:15.320|Chg%:+0.040 - TradingKey
SDGR|Schrodinger Inc|Price:14.970|Chg%:-0.160 - TradingKey
Schrodinger, Inc. Revenue Breakdown – LS:A2PY7M - TradingView
Schrödinger, Inc. (SDGR) stock price, news, quote and history - Yahoo Finance UK
Schrodinger Inc (SDGR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers - marketscreener.com
Schrödinger, Inc. (SDGR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
Schrödinger to announce Q2 2026 results on August 5 - scanx.trade
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5 - BioSpace
Enterprise value to revenue forward of Schrodinger, Inc. – FWB:43Z - TradingView
Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc. - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)July 20, 2026 - BioSpace
Schrodinger (SDGR) Grants Restricted Stock Units to New Employees - GuruFocus
Schrodinger grants new hires RSUs covering 3,691 shares under inducement plan - Bitget
Schrödinger (SDGR) Jefferies London Healthcare Conference 2025 Summary - Quartr
Schrödinger (SDGR) AGM 2026 Summary - Quartr
Schrödinger (SDGR) Jefferies London Healthcare Conference 2024 Summary - Quartr
Schrodinger CFO Rachit Jain sells $13,647 in stock - Investing.com UK
Schrodinger CFO Rachit Jain sells $13,647 in stock By Investing.com - Investing.com Nigeria
Form 4 Schrodinger Inc For: 17 July By Investing.com - Investing.com Nigeria
Schrodinger (SDGR) CFO sells 875 shares for RSU tax withholding - Stock Titan
Enterprise value to revenue forward of Schrodinger, Inc. – DUS:43Z - TradingView
Form 144 Schrodinger For: 16 July By Investing.com - Investing.com Canada
Hong Kong Stock Market Alert | Simcere Pharmaceutical (02096) Surges Over 6% Intraday Following Global Drug Discovery and Development Collaboration Agreement with U.S.-based Schrödinger, Inc. - 富途牛牛
Price to book forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
Price to earnings forward of Schrodinger, Inc. – BOATS:SDGR - TradingView
BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail
Enterprise value to EBITDA forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development - GlobeNewswire Inc.
Price to sales forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
(SDGR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Schrodinger Inc. (SDGR) Jumps 3.73% as Software-Driven Drug Discovery Gains TractionGap and Reverse - dars.gov.et
Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR) - Seeking Alpha
Schrodinger explores computational chemistry. Nasdaq biotech stock leans on its platform - AD HOC NEWS
Citigroup Downgrades Schrödinger (SDGR) - MSN
SDGRSchrodinger Inc Latest SEC Filings - Finviz
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock By Investing.com - Investing.com Nigeria
Schrodinger Inc (SDGR) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.79%
大文字化:
|
ボリューム (24 時間):